Informazioni sul prodotto
Taselisib is a small-molecule inhibitor of phosphatidylinositol 3-kinase (PI3K) and PI3K-related protein kinases. Taselisib is being investigated as a potential treatment for multiple myeloma, chronic lymphocytic leukemia, and other cancers. Taselisib is an orally available, potent, selective, and ATP competitive inhibitor of PI3K isoforms p110α and p110β. It has been shown to have antiproliferative effects in preclinical models of multiple myeloma, chronic lymphocytic leukemia, solid tumors, and hematopoietic stem cells. It also has anti-inflammatory properties that may be due to its inhibition of the production of proinflammatory cytokines such as tumor necrosis factor-α (TNFα), interleukin 1β (IL1β), IL6, IL8 and IL10.
Proprietà chimiche
Richiesta tecnica su: 3D-BGC30530 1-Isopropyl-3-methyl-1H-1,2,4-triazole
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
